However, NLRP3 inflammasome is activated by a tumor-derived signal in the immune cells that cleaves pro-IL-1β to active IL-1β by caspase-1 and finally promotes thrombosis in the IL-1β/NLRP3 pathway [66]. The gene discussed is NLRP3; the disease is neoplasm.